Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence.

Esmee P Hoefsmit,Franziska Völlmy,Elisa A Rozeman,Irene L M Reijers,Judith M Versluis,Liesbeth Hoekman,Alexander C J van Akkooi,Georgina V Long,Dirk Schadendorf,Reinhard Dummer,Maarten Altelaar,Christian U Blank

Cancer research communications（2023）

引用 1|浏览51

暂无评分

摘要

LRG1 could serve as a potential target and as a biomarker to identify patients with high risk for disease recurrence, and consequently benefit from additional therapies and intensive follow-up.

查看译文

关键词

melanoma,disease progression

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要